The quest for increased productivity and better process control combined with patient safety has encouraged biopharmaceutical companies to use chemically defined media for cell culture.
Michelle Lea, PhD
Advertisement
Michelle Lea, PhD, is a senior fermentation development scientist at Eden Biodesign Ltd.
Articles by Michelle Lea, PhD
Advertisement
Latest Updated Articles
Balancing Media Development with Patient SafetyJune 2nd 2010
Advertisement
Advertisement
Trending on BioPharm International
1
Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP
2
BioNTech, BMS to Pair Pumitamig With Trodelvy in Phase 3 First-Line TNBC Trial
3
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
4
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
5